Voronoi, Inc. (KOSDAQ:310210)

South Korea flag South Korea · Delayed Price · Currency is KRW
108,400
-2,400 (-2.17%)
Mar 28, 2025, 3:30 PM KST
199.03%
Market Cap 1.95T
Revenue (ttm) n/a
Net Income (ttm) -32.61B
Shares Out 17.97M
EPS (ttm) -1,860.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 133,447
Average Volume 271,733
Open 111,900
Previous Close 110,800
Day's Range 105,500 - 111,900
52-Week Range 28,350 - 153,000
Beta 1.99
RSI 36.82
Earnings Date Mar 21, 2025

About Voronoi

Voronoi, Inc. researches, develops, and discovers small molecule kinase inhibitors in South Korea. Its products pipeline includes VRN01, an oral leucine rich repeat kinase 2 inhibitor targeting glioblastoma multiforme to treat brain and pancreatic cancers; VRN07, VRN06, and VRN11 for the treatment of lung cancer; VRN08 and VRN10 to treat breast cancer; and VRN02 for the treatment of rheumatoid arthritis and atopic dermatitis. The company’s products pipeline also comprise VRN04-1 to treat autoimmune diseases; VRN04-2 for the treatment of multipl... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 130
Stock Exchange KOSDAQ
Ticker Symbol 310210
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.